Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1920 1
1954 1
1963 3
1965 1
1974 1
1976 1
1977 4
1978 3
1979 4
1980 1
1983 2
1984 1
1985 3
1986 3
1987 9
1988 2
1989 5
1990 4
1991 2
1992 2
1994 1
1995 4
1996 1
1997 1
1998 1
2000 1
2001 2
2002 1
2003 6
2004 2
2005 3
2007 3
2008 7
2009 1
2010 6
2011 8
2012 4
2013 7
2014 7
2015 6
2016 17
2017 13
2018 9
2019 8
2020 11
2021 16
2022 18
2023 20
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. Tricco AC, et al. Among authors: weeks l. Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4. Ann Intern Med. 2018. PMID: 30178033 Free article.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. Higgins JP, et al. Among authors: weeks l. BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928. BMJ. 2011. PMID: 22008217 Free PMC article.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Monoclonal gammopathy of undetermined significance.
Mouhieddine TH, Weeks LD, Ghobrial IM. Mouhieddine TH, et al. Among authors: weeks ld. Blood. 2019 Jun 6;133(23):2484-2494. doi: 10.1182/blood.2019846782. Epub 2019 Apr 22. Blood. 2019. PMID: 31010848 Free article. Review.
TET2-mutant clonal hematopoiesis and risk of gout.
Agrawal M, Niroula A, Cunin P, McConkey M, Shkolnik V, Kim PG, Wong WJ, Weeks LD, Lin AE, Miller PG, Gibson CJ, Sekar A, Schaefer IM, Neuberg D, Stone RM, Bick AG, Uddin MM, Griffin GK, Jaiswal S, Natarajan P, Nigrovic PA, Rao DA, Ebert BL. Agrawal M, et al. Among authors: weeks ld. Blood. 2022 Sep 8;140(10):1094-1103. doi: 10.1182/blood.2022015384. Blood. 2022. PMID: 35714308 Free PMC article.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Prediction of risk for myeloid malignancy in clonal hematopoiesis.
Weeks LD, Niroula A, Neuberg D, Wong W, Lindsley RC, Luskin M, Berliner N, Stone RM, DeAngelo DJ, Soiffer R, Uddin MM, Griffin G, Vlasschaert C, Gibson CJ, Jaiswal S, Bick AG, Malcovati L, Natarajan P, Ebert BL. Weeks LD, et al. NEJM Evid. 2023 May;2(5):10.1056/evidoa2200310. doi: 10.1056/evidoa2200310. Epub 2023 Apr 25. NEJM Evid. 2023. PMID: 37483562 Free PMC article.
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.
Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. BMJ. 2023 Apr 24;381:e073725. doi: 10.1136/bmj-2022-073725. BMJ. 2023. PMID: 37094878 Free article. Clinical Trial. No abstract available.
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED, Schuermans A, Cho SMJ, Sporn ZA, Uddin MM, Paruchuri K, Nakao T, Yu Z, Haidermota S, Hornsby W, Weeks LD, Niroula A, Jaiswal S, Libby P, Ebert BL, Bick AG, Natarajan P, Honigberg MC. Gumuser ED, et al. Among authors: weeks ld. J Am Coll Cardiol. 2023 May 23;81(20):1996-2009. doi: 10.1016/j.jacc.2023.03.401. J Am Coll Cardiol. 2023. PMID: 37197843 Free PMC article.
232 results